The FDA today reported that so far, it has found no signs of heart risks associated with long-term use of the drugs Prilosec and Nexium. disease (GERD) and stomach and duodenal ulcers. Prilosec is ...

Background: On May 29, 2007 AstraZeneca, the maker of Prilosec (omeprazole) and Nexium (esomeprazole), sent FDA data from two long-term studies in patients with severe gastroesophageal reflux disease ...

The US Food and Drug Administration (FDA) today issued its final assessment of two small, open, long-term, clinical studies in patients with gastro-esophageal reflux disease (GERD), comparing ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration warned today that patients taking the ...

FDA officials say it will need three months to thoroughly analyze data on possible cardiac risk associated with Nexium and Prilosec, both proton pump inhibitors used to treat heartburn and reflux ...

CHICAGO -- U.S. employers, struggling to tame double-digit health inflation, are putting the squeeze on AstraZeneca's ulcer drug Nexium, a product the Anglo-Swedish drug maker sorely needs to boost ...

WASHINGTON — U.S. regulators said Monday that they had cleared AstraZeneca’s bestselling heartburn drugs Prilosec and Nexium of links to heart problems, but disclosed a review of a potential risk of ...

A federal judicial panel has transferred more than 200 cases to New Jersey involving heartburn medications Nexium and Prilosec just six months after it refused a similar request. In a notably lengthy ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. AstraZeneca (LSE: AZN) settled its patent litigation with Teva Pharmaceutical ...

Pharmaceutical companies usually provide innovation that helps improve the lives of patients. But AstraZeneca marketed Nexium, a drug that should have never been approved in the first place. The ...